GARDNER MARK A 4

What Happened

• Mark A. Gardner, President of GeneDx Holdings Corp. (WGS), received an award of 35,441 restricted stock units (RSUs) on 2026-06-29. The units are recorded at $0.00 per share (a derivative grant) and represent contingent rights to receive Class A common stock upon settlement for no consideration. This is a compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-29; Filing date: 2026-07-01 (appears timely).
• Transaction type/code: Award/Grant (A); recorded as a derivative grant at $0.00 per unit.
• Number of units granted: 35,441 RSUs.
• Shares owned after transaction: Not stated in the provided filing details.
• Footnotes:
  • F1: Each RSU converts to 1 share of Class A common stock upon settlement for no consideration.
  • F2: Vesting — 25% of the award vests each July 1, with the first tranche vesting on July 1, 2027, subject to continued service. RSUs do not have an expiration date; they either vest or are canceled before vesting.

Context

• RSU grants are a form of equity compensation tied to continued service and vesting dates; they do not represent a market purchase and do not necessarily signal the insider is buying shares on the open market. Upon settlement (vesting), the units convert into shares for the recipient per the stated schedule.